Previous studies have suggested that, in vivo, activated T lymphocytes and neutrophils are important in immunity to nontypable Haemophilus influenzae. We now extend this work by showing that neutrophils pretreated with products of activated T lymphocytes or activated macrophages show significantly enhanced killing of nontypable H. influenrae. Lymphotoxin, a product of activated T lymphocytes, significantly enhanced the neutrophil-mediated killing of nontypable H. infi uenzae, and tumor necrosis factor, produced by activated T lymphocytes as well as macrophages stimulated by activated T lymphocytes, also significantly increased the bactericidal activity of neutrophils. These cytokine-induced effects were seen with short pretreatment times of neutrophils and were maximal by 30 min. The killing of H . infiuenzae by neutrophils required the presence of heat-labile opsonins. In the absence of these opsonins, both tumor necrosis Nontypable Haemoph ilus infiuenzae is a co mmo n resp iratory pa thogen. It is carried in the nasopharynx of 70-80% of health y childr en (1). Coloniza tio n rates incr ease dur ing respirato ry illn ess (2) . In particul ar, colonizat ion of the nasoph arynx w ith nontypable H. infi uenzae may exceed 95% at the time of otitis media (3) , when the organism may compose 50% of the total bacterial flora (4). Although invasive disease, such as bacteremia, is uncommon with nontypabl e H. infl uenza e, local infection is frequent. Nont ypable H. infiu enzae is the second leading cause of acute otitis media and sinusitis and the lead ing ca use of recurrent or chronic otitis media in children (5-8).
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Th e protective role of antibody against nont ypable H. infiuenzae respi ratory infections in both humans and rat mod els is now qu estion abl e. High levels of antibo dy to this org an ism are presen t in se rum, saliva, and sputum of patients with chronic bronchitis (9, 10) , and in on e study the level of anti body in factor and Iymphotoxin were unable to promote the killing of the bacteria by neutrophils. Furthermore, the results showed that tumor necrosis factor-primed neutrophils displayed significantly increased expression of CR3 and CR4 that was associated with increased phagocytosis of complement-opsonized nontypable H. infiuenzae. These cytokines may play an important role in immunity toward nontypable H. infl uenzae by stimulating neutrophil bactericidal activity. (Pediatr Res 37: [155] [156] [157] [158] [159] 1995) Abbr eviations TNF, tumor necrosis factor LT ,lymphotoxin CR3, complement receptor type 3 (CD18/CD11b) CR4, complement receptor type 4 (CD18/CD11c) HBSS, Hanks' balanced salt solution thes e fluid s cor related directly wi th the incidence of infectio n and mo rtality observed in these patien ts (10) . This is despi te the fact that bactericidal antibody to no ntypable H. infiuenzae has been demonstrated and has been shown to be protective in nontypable H. infiuenzae-related otitis medi a (11-13). Patient s wit h chro nic bronch itis can suppo rt high co loniza tio n rates of non typable H. infiuenzae in the pres ence of significant level s of ba ctericidal and opson ic activity in the serum (14) . It has been suggested that the IgA anti-Haemophilus antibody in bronchopulmon ary secretio ns blocks the bacteric idal and op so nizing effects of antibod y to the bacteria (15) .
Using a rat mo del and immunization by intr a-Peyer' s patch inj ection wit h nont ypable H. infiuenzae, it wa s shown that im munity could be transferred to naive reci pients by T lymphocytes, but a primary protective role for antibody co uld not be established. Protection by T lymphocytes was man ifested by increased cle aran ce of bac teria from the lun gs (16) (17) (18) . No cle ar co rrelation w as fo und between local or syst emi c antibody and bacterial clearance, and it wa s concluded that bacterial clearance is accelera ted by factors that induce alterati on s in phagocytes (17) . Immun ized nude rats were less capab le of 156 TAN ETAL. accelerated clearance of nontypable H. infiuenzae compared with normal rats (16) . These findings suggest that mechanisms for clearance of H. infiue nza e from the respiratory tract other than local or systemic antibody need to be investig ated.
Recent evidence supports the concept that T lymphocytes are involved in recruiting and activating neutrophils at sites of infection (19) . Czuprynski et al. (20) showed that immunologically specific T lymphocytes, in an antigen-and dosedependent manner, recruited neutrophils to a specific site. The recruited neutrophils, specific for Listeria monocytogenes , expressed high levels of bactericidal activity. Appelb erg and Silva (21) demonstrated that T cells were important for inducing a persisting neutrophilia during intraperitoneal infection with Mycobacterium avium . Injection of antigen-pulsed spleen cells from M. avium-infected mice into the peritoneal cavity of normal mice caused a neutrophil accumulation at this site. Studies with a pathogenic free-living amoeba, Naegleria fowle ri, demonstrated that neutrophils play an important role in immunity to Naeg leria (22) . Mice immune to this amoeba after immunization with killed antigen generated neutrophil s that showed enhanced responses to the tripeptide f-Met-Leu-Phe (23) when challenged a second time with the antigen. Other studies have suggested that cell-mediated immune responses may be crucial for the activation of neutrophil-mediated killing of No ca rdia asteroides in mice (24) .
We have previously found that human T lymphocytes when activated by phytohemagglutinin-phorbol myristate acetate in culture were able to activate the neutrophil oxygen-dependent respiratory burst (25) . In these studies, it was demonstrated that it was necessary for T lymphocytes to directly bind the neutrophils to induce these effects and that T cells actually primed the neutrophils for an increased response to f-Met-Leu-Phe and phorbol myristate acetate (25) . Some evidence also has been presented suggesting that macrophages regulate the accumulation of neutrophils during inflammation (26) .
Cytokines produc ed exclusively or preferentially by stimulated T lymphocytes have been shown to activate a range of neutroph il functions (27) . These include LT (28 -31), interferon-y (also a major product of natural killer cells) (29) (30) (31) (32) (33) (34) , and IL-2 (35, 36) .
Other cytokines of interest that may have an effect on neutrophil activation are produced primarily by macrophages but can also be released by stimulated T cells. These include TNF (30, 33, (37) (38) (39) (40) 41) , IL-l (27, 29) , granulocy te-colonystimulating factor (34, 42) , and IL-8 (43) .
All of these cytokines can, in various ways, regulate the inflammatory response by acting on the neutrophil. They have the ability to increase neutrophil adhesion to the endothelium, to attract cells to infection foci via chemotaxis, to retain leukocytes at inflammatory sites by their migration inhibitory properties, and to activate the neutrophils with a subsequent increase in antimicrobial activity. In this study, the ability of the two related cytokines TNF and LT to alter the neutrophilmediated killing of nontypable H. infiuenzae has been investigated. The results show that both cytokines are effective in priming neutrophils to increase their bactericidal activity for nontypable H. influe nzae.
METHODS

Bacteria.
A nontypable H. influenrae was used in all experiments. The bacteria were grown on chocolate agar plates at 37°C for 24 h, harvested, and suspended in HBSS . The bacterial concentration was quantitated immediately before use in a hemacytometer chamber. At the same time, an inoculum was made and spread on chocolate agar for verification of numbers of viable bacteria by colony formation.
Ne utrophils. Neutrophils were prepared from the blood of healthy volunteers by the rapid-single-step method (44) . The blood was mixed with heparin and layered onto a high density Ficoll-Hypaque medium (1.114 g/L) and centrifuged at room temperature for 30 min at 200-600 X g. After centrifugation, the mononuclear leukocytes appeared in a band at the interface, the neutrophils formed a band 1 cm below, and the red cells centrifuged to the bottom of the tube. The neutrophils in the second band were harvested and washed three times in HBSS. The neutrophils were of > 96% purity and > 99% viability by trypan blue dye exclusion.
The study was approved by the Ethics Committee of the Women's and Children's Hospital. Informed consent was obtained from the volunteers.
Bactericidal activity. Neutroph il bactericidal activity for nontypable H. influenzae was carried out essentially as described previously for Stap hylococcus aureus (45) . To 100 ILL of neutrophils (5 X 10 6 ) were added either 100 ILL (100 U) of TNF, 200 U of LT, or 100 ILL of HBSS, and the mixtures were incubated at 37°C for 30 min. After incubation, 1 X 10 6 nontypable H. infiuenzae were added and the volume made up to 500 ILL with HBSS. Because of the sensitivity of nontypable H. infiuenzae to serum complement-mediated bactericidal activity, human serum deficient in the sixth component of complement (C6D serum) was used in the assay as an opsonin at 4% (vol/vol) final concentration. C6D serum was prepared by depleting C6 from human serum by immunoadsorption (Sigma Chemical Co., St. Louis, MO). Controls were added in which the cytokine diluent (HBSS) was used in place of cytokines. In other experiments, the cytokine preincubation time and also the cytokine concentrations were varied. The tubes were gassed with 5% CO 2 -air mixture and incubated at 3rC with end-toend mixing. Samples were taken at 0 and 30 min, diluted in water, and plated on chocolate agar for determination of viable bacterial count.
Flow cytometric analysis of integrin expression. The expression of integrins on neutrophil surfaces was examined as previously described (45) . Neutrophils (5 X 10 5 ) were incubated at 4°C/30 min in the presence of saturating concentrations of MAb. After incubation, the cells were washed and stained at 4°C/3D min with fluorescein-conjugated second antibody (goat anti-mouse IgG, Organon Teknika Corp., West Chester, PA) in the presence of 25% (vol/vol) autologous plasma. The cells were washed and fixed with 1% (wt/vol) paraformaldehyde. Fluorescence distribution was measured in a Becton Dickinson FACS analyzer (Mountain View, CA). Fluorescence values were corrected by subtraction of values for an isotype-matched negative control. Anti-CDlla (HB 202, IgG1) was TSI/22 (45) , anti-CD11b (lOM-l, IgG) was from Immunotech, Marseilles, France, and anti -CDllc (kB90, IgG1) was from Dakopatts, Glostrup, Denmark. Phagocytosis. Phagocytosis of nontypable H. infiuenzae was measured by a previously reported assay using FITC-Iabeled bacteria and flow cytometr y analyses (46) . The bacteria were labeled with FITC (Sigma) as previously described (46) and adjusted to 1 X 10 9 /mL in HBSS. The bacteria (1 X 10 8 ) were then mixed with TNF-primed or diluent-treated neutrophils (5 X 10 6 ) in a total volume of 500 p,L that included 4% human C6D serum. After a 20-min incubat ion at 37°C a 50-p,L sample was taken, added to 500 p,L of cold HBSS, and then treated with 0.065% trypan blue to quench fluorescence from adhered bacteria. The fluorescence due to internalized bacteria was measured on a FACSCAN (Lysis II program, Becton Dickinson, Sydney, Australia).
Cytokines. Human recombinant TNF was produced by Genentec Inc. (San Francisco, CA) and was kindly provided by Dr. G. R. Adolf, Ernst-Behringer Institute, Vienna, Austria. The recombinant TNF was produced in Escherichia coli, purified, and had a sp act of 6 X 10 7 U/mg as assayed by the supplier (cytotoxicity on actinomycin D-treated murine connective tissue cell line L929). Human recombinant LT was also from Genentec (provided by Dr. Adolf) and contained a sp act of 1.2 X 10 8U /mg. The preparations were > 99% pure and estimated to contain < 0.125 endotoxin units/mL of endotoxin.
Statistics. The data are presented as percentage of bacteria l survival and analyzed using the t test for paired data.
RESULTS
Treatment of human neutrophil s with TNF significantly increased the ability of the cells to kill nontypable H. influenzae when serum opsonins were present (Fig. 1) . TNF induced a 5-fold decrease in the survival of the bacteria ( p < 0.01).
When serum recognition factors were inactivated by heating at 56°C/30 min, TNF failed to stimulate this activity (data not pres ented). The effects of TNF were evident at a TNF concentration as low as 1 U/5 X 10 6 cells (p < 0.001) (Fig. 2) . The related cytokine LT was also effective in enhancing neutrophil bactericidal activity. Neutrop hils pretreat ed with LT showed significantly enhanced bactericidal activity (Fig. 3) ( p < 0.01). Bacterial survival was decreased approxim ately 4-fold by treatment with LT. Studies on the concentrationrelated effects showed that 50 U of LT were required to induce significant enhancement (p < 0.05) of bactericidal activity (Fig. 4) .
Preincubation times of 30 to 60 min with TNF were most effective in enhancing neutrophi l bacterici dal activity (Fig 5) . The degree of enhancement was gradually reduced as the preincubation time was reduced to less than 30 min, although the simultaneous addition (0 time) of TNF and bacteria still resulted in a significant (p < 0.05) enhancement of the neutrophil bacterial killing. activity were within the physiologic concentrations achieved in vivo (46) . Inasmuch as both TNF and LT were effective in this system, the results raise the possibility that macrophages, the major producers of TNF , and T lymphocytes, responsible for producing LT, may play an important role in immunity to nontypable H. inftuenza e. Our results may explain previous findings that showed that activated T lymphocytes and neutrophils were import ant for increasing the clearance of H. influenzae in rat lungs (16) . From our studies, we suggest that these T lymphocytes enhance the neutrophil bactericid al activit y against H. infiuenza e both by the release of LT and the activ ation of macrophages for release of TNF. The effects of TNF and LT were seen in the prese nce of heat-labile serum factors. These were required for neutrophil killing of H. infiuenzae. When these factor s were absent , neither TNF-nor LT-treated neutrophils show ed any bactericidal activity. This is similar to our previous findings with S. aureus (45) . Interaction of TNF and LT with neutrophils leads to increased expression of CR3 (45, 48) , which allows the interaction of neutrophils with the C3bi opsonized bacteria. We have confirmed that TNF increa ses the expression of both CR3 and CR4 and now demons trate that this enhan cement of expression of CR3 and CR4 leads to enhanced phagocytosis of complement-coated H. infiuenzae. The increase in the number of bacteria phagocytosed and the well-established associated increase in the ability of the TNF/LT-primed neutrophils to show increased release of oxygen-d erived reactive species and release of lysosomal enzymes (27) are most likely responsible for the enhanced microbial killing seen.
The role of antib ody in immunity and protection from nontypable H. infiuenzae infection remains unknown (16 -18) , and it appears that T lymphocytes and production of neutrophil-activating cytokines are important in immunity against this organism (16-1 8) . T lymphocytes are important in recruiting macrophages and neutrophils in the lungs and, as demon- 
DISCUSSION
Additional studies showed that, under these conditi ons, TNF enhanced the surface express ion of the neutrophi l integrin receptors CR3 (p < 0.001) and CR4 (p < 0.01) (Fig. 6 ).
However, TNF was unable to cause a significant chang e in the expres sion of the other integrin recept or, leukocyte functional antigen-l (CD18/CDlla) (data not presented). Associ ated with this change in CR3 and CR4 expre ssion, the TNF-primed neutrophils showed significantly enhanced (p < 0.05) phagocytosis of nontypab le H. influ enzae (Fig. 6) .
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The results demonstrate that preexposure of human neutrophils to TNF or LT significan tly increases their ability to kill nontyp able H. infiuenzae. The concentrations of cytokines required to achieve enhancement of neutrophil bactericidal strated by our studies, they activate neutrophils by releasing lymphokine s, leading to increased neutrophil killing of nontypable H. influenzae and possibly clearance of the bacteria from the lungs. Our data suggest that identification of H. infiu enzae antigens that stimulate T cells to produce cytokines such as LT could prove to be useful in the search for appropriate vaccine antigens.
